Novel 3D high-content/throughput assay with mobile device-based data acquisition
Award amount
$150,000Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CHEMOSEN3D INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- LH32V6UMM1K5
- Solicitation number
- PA13-234
- Topic code
- NIEHS
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Numeric Expansion of CD-19 Specific T cells in Magnetic 3D Culture
- Development of high-throughput cardiotoxicity and hepatotoxicity assays with magnetic 3D bioprinting
- A novel 3D cell culture human uterine contractility assay for high-throughput scr
- SBIR Phase II: In Vitro 3D Tissue Model for Toxicity Screening and Drug Discovery
- SBIR Phase I:In Vitro 3D Lung Tissue Model for Drug Discovery and Toxicity Screening
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Bioinspired Green Glycolipids as Fugitive Dust Mitigation Agents
- Supercritical Fluid Cartridges for Calibration of Air Pollution Sensors
- Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle interventions to lose weight and reduce EDC exposure in individuals with overweight/obesity
- High-Resolution Ground-Level AQ Monitoring System Using Hyper-local Low-cost Sensor Nodes and AI Forecasting
- Bringing PFAS Monitoring Home: An Integrated Magnetic Nanoparticle and Lateral Flow Assay System
Research funding history
6 SBIR/STTR records share this UEI (2010–2018). Reported award amounts total $2,215,805. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation